Markets:

Overview

News

Currencies

International

Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

31.04 -3.03 (-8.89%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies ↗

April 12, 2022

Nanobiotix SA (NASDAQ: NBTX)

Via Benzinga

NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3

April 11, 2022

From NANOBOTIX

Via Business Wire

NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F

April 08, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

April 07, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results

March 30, 2022

From NANOBIOTIX

Via Business Wire

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022

March 16, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

February 10, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer

February 09, 2022

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 02, 2022

Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6...

Via Benzinga

NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4

January 26, 2022

From NANOBIOTIX

Via Business Wire

Is Oncolytics Biotech's GOBLET Study Making Headway in the Fight Against Pancreatic and Colorectal Tumors? ↗

January 25, 2022

Photo by Lucas Vasques on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

January 11, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets

January 10, 2022

From NANOBIOTIX

Via Business Wire

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer

January 05, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022

January 04, 2022

From Nanobiotix

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

December 08, 2021

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...

Via Benzinga

NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference

November 17, 2021

From NANOBIOTIX

Via Business Wire

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkpoint Inhibitor Combination

November 09, 2021

From NANOBIOTIX

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

November 08, 2021

From Nanobiotix

Via Business Wire

NANOBIOTIX to Participate in a Fireside Chat at the Jefferies London Healthcare Conference

November 03, 2021

From Nanobiotix

Via Business Wire

The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children ↗

October 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...

Via Benzinga

NANOBIOTIX Announces 18.1 Month Median Overall Survival for 41 Evaluable Elderly and Frail Patients With HNSCC in Phase I Expansion Evaluating Nbtxr3 as a Single Agent Activated by Radiotherapy

October 24, 2021

From NANOBIOTIX

Via Business Wire

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

NANOBIOTIX Provides Third Quarter Operational and Financial Update

October 20, 2021

From NANOBIOTIX

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

October 08, 2021

From Nanobiotix

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Nanobiotix S.A. - ADSs (NQ:NBTX)

All News about Nanobiotix S.A. - ADSs

Starting at $3.75/week.

Subscribe Today